Why this income stock is outperforming its peers today

The Atlas Arteria Group (ASX: ALX) share price jumped and it isn't only its good full year results that's driving the stock.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Atlas Arteria Group (ASX: ALX) share price is defying the broader market gloom after management said it would pay out a better than expected dividend.

Shares in the toll road operator jumped 2.3% to $8.16 in late afternoon trade when the S&P/ASX 200 (Index:^AXJO) (ASX:XJO) index shed 0.7% of its value.

Fellow infrastructure stocks like the Transurban Group (ASX: TCL) share price and APA Group (ASX: APA) share price are also trading in the red as worries about the economic fallout from the growing coronavirus scare leave few places for investors to hide.

Overtaking lane

Atlas Arteria is proving to the exception even as worries of a virus outbreak in Europe and the US intensifies. The company's assets are in both continents.

But investors aren't bothered as management handed in its full year profit results that showed a near 9% increase in adjusted net profit to $178.2 million for 2019 (it's financial year ends in December).

The good result was driven by a 5.5% increase in profits from Atlas Arteria's stake in French toll road network APRR and Warnow Tunnel in Germany, while its US Dulles Greenway asset detracted.

Better than expected dividends

Management declared an 18 cent a share distribution to shareholders for the second half of 2019 and said it will pay a similar amount for the first half of 2020.

This represents a 6% increase in the company's previous guidance back in November and a 20% uplift in 2019 dividends.

The increase payout is a confidence booster for investors and reflects management's positive outlook for the group – notwithstanding the COVID-19 virus outbreak.

Reaping the rewards

"The 2019 year was a pivotal one for Atlas Arteria," said the company's chief executive Graeme Bevans.

"We built a new corporate team, managed a seamless transfer of management arrangements and, delivered strong underlying performance. We secured arrangements to increase Atlas Arteria's indirect interest in APRR and become a truly independent group."

Atlas Arteria paid $2.3 million in costs associated with internalising management of the assets. It also had to cough up $20.7 million to Macquarie Group Ltd (ASX: MQG) in fees under a transition agreement.

Foolish takeaway

Atlas Arteria spun out of Macquarie and the operations of the managed by the investment bank before the internalisation exercise.

Defensive income stocks have been well supported over the past year or two. Record low interest rates and an increasingly uncertain economic environment are driving interest in such investments. This trend is unlikely to wane in 2020.

Motley Fool contributor Brendon Lau owns shares of Macquarie Group Limited. The Motley Fool Australia owns shares of and has recommended Macquarie Group Limited and Transurban Group. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Up 680% since July, here's why 2025 was a breakout year for this hot ASX stock

With consistent contract wins, FDA clearance, and backing from Pro Medicus, 4D Medical is showing that there is a commercial…

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Share Gainers

4 ASX 200 stocks smashing the benchmark this week

Investors have been piling into these four ASX 200 stocks this week. Let’s see why.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Bendigo Bank, NextDC, Nuix, and Vulcan Energy shares are rising today

These shares are ending the week on a high. But why?

Read more »

Girl with painted hands.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy Thursday for ASX investors.

Read more »

Excited couple celebrating success while looking at smartphone.
Share Gainers

Why BHP, DroneShield, Lotus Resources, and Nuix shares are pushing higher today

These shares are having a better day than most on Thursday. But why?

Read more »

Three children wearing athletic short and singlets stand side by side on a running track wearing medals around their necks and standing with their hands on their hips.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy hump day for the ASX.

Read more »

A man sees some good news on his phone and gives a little cheer.
Share Gainers

Why 4DMedical, Dateline, Predictive Discovery, and Wildcat shares are racing higher

These shares are having a good session on hump day. But why?

Read more »